Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses-Reference-Cited by-同舟云学术

Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses

Published:2023-03 Issue: Volume:514 Page:113440
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Pisanic Nora,Antar Annukka A.R.,Kruczynski Kate L.,Gregory Rivera Magdielis,Dhakal Santosh,Spicer Kristoffer,Randad Pranay R.,Pekosz Andrew,Klein Sabra L.,Betenbaugh Michael J.,Detrick Barbara,Clarke William,Thomas David L.,Manabe Yukari C.,Heaney Christopher D.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Delayed rise of Oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in a longitudinally sampled cohort of COVID-19 outpatients;Antar;Open Forum Infect. Dis.,2021

2. Mucosal immune response in BNT162b2 COVID-19 vaccine recipients;Azzi;eBioMedicine,2022

3. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020;Bajema;JAMA Intern. Med.,2021

4. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study;Blair;Open Forum Infect. Dis.,2021

5. Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and metaanalysis;Bobrovitz;PLoS One,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance evaluation of four kits for the detection of neutralizing antibody against SARS-CoV-2 in human serum;Journal of Clinical Virology Plus;2024-09

2. SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, USA, 2021 to 2022;Annals of Work Exposures and Health;2024-08-05

3. COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort;Science Advances;2024-06-14

4. SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, 2021 to 2022;2024-03-08

5. A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland;Microbiology Spectrum;2023-08-17